Cipla

CIPLA · NSE · Pharma · India

₹1,351.80

-0.3%

as of Jun 19, 2026, 9:59 AM

52-week range

₹1,165.70 – ₹1,673.00

Revenue (FY2026)

₹28,163 Cr

Net margin

13.8%

Volume

1,476,641

New to these? P/E, ROE, ROCE and more in Learn.

Ask MarketChacha about CIPLA

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Revenue trend

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2026₹28,163 Cr₹3,879 Cr13.8%
FY2025₹27,548 Cr₹5,273 Cr19.1%
FY2024₹25,774 Cr₹4,122 Cr16.0%
FY2023₹22,753 Cr₹2,802 Cr12.3%

Quarterly

PeriodRevenueNet profitEPSNet marginROE
2026Q1₹6,541 Cr₹555 Cr8.5%
2025Q4₹7,074 Cr₹676 Cr9.6%
2025Q3₹7,589 Cr₹1,351 Cr17.8%
2025Q2₹6,957 Cr₹1,298 Cr18.7%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Data from official filings (SEC/BSE), Yahoo Finance, and Google News. Verify with the linked sources before acting.